Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
Status:
Completed
Trial end date:
2019-11-25
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if fentanyl nasal spray can help to
control shortness of breath in patients who have been treated or are being treated for
cancer.
Fentanyl is commonly used for treatment of cancer pain. It may help patients with their
shortness of breath as well.
In this study, fentanyl will be compared to a placebo. A placebo is not a drug. It looks like
the study drug but is not designed to treat any disease or illness. It is designed to be
compared with a study drug to learn if the study drug has any real effect.